Zebrafish (*Danio rerio*) exhibit 70--80% gene sequence homology with humans and share structural similarities with vertebrates ([@kfy250-B17]; [@kfy250-B19]). Therefore, their embryos are used as an alternative model for developmental toxicity screening of drugs and chemicals ([@kfy250-B8]; [@kfy250-B48]). The possibility of holistic assessment in a small-scale system, the ability to produce large numbers of progeny, and the transparency of the embryos and their rapid development have made the model particularly attractive and led to the development of high-throughput assays ([@kfy250-B41]; [@kfy250-B53]).

Results from small-scale pilot studies have demonstrated a high concordance between zebrafish and mammalian developmental toxicity with an overall concordance of 72--92% ([@kfy250-B8]; [@kfy250-B21]; [@kfy250-B29]; [@kfy250-B48]; [@kfy250-B55]). However, in interlaboratory variability studies ([@kfy250-B3]; [@kfy250-B20]), some inconsistencies with respect to concordance analysis were also observed. The concordance of individual laboratories for developmental toxicity or teratogenic classification ranged between 60% and 70% when compared with mammalian data, but only 5 of 20 compounds were similarly classified (ie, teratogenic or nonteratogenic) by all 4 participating laboratories ([@kfy250-B20]). In a subsequent study with 37 compounds and 2 laboratories, a concordance of 71% for teratogen classification was observed ([@kfy250-B3]). This variability between laboratories may have been partly caused by the visual observation and classification of developmental alterations by an individual technician or researcher and limited standardization. Hence, the approach currently used for developmental toxicity screening in zebrafish embryos might be biased by the experience and accuracy of the observer. Furthermore, observations are often not documented by storing the relevant images, thus making verification and reanalysis of data difficult.

Previous phenotypic image analyses have focused on fluorescent imaging for measuring, that is, cardiovascular development ([@kfy250-B31]), cardiovascular function ([@kfy250-B10]; [@kfy250-B31]; [@kfy250-B32]; [@kfy250-B58]), and angiogenesis ([@kfy250-B32]; [@kfy250-B57]). There are few published studies using automatic phenotypic image analysis for bright-field microscope images without fluorescent markers or staining ([@kfy250-B2]; [@kfy250-B16]; [@kfy250-B24]; [@kfy250-B34]; [@kfy250-B47]). Some of these studies were limited to the identification of specific phenotypes such as lethality ([@kfy250-B1]; [@kfy250-B34]), hatching status ([@kfy250-B34]), changes in pigmentation ([@kfy250-B2]; [@kfy250-B47]), or lack of eyes ([@kfy250-B47]). One study aimed at developing a computational malformation index through the use of morphometric parameters (eg, total body area, convexity) in combination with a very brief human visual assessment ([@kfy250-B16]). That method was more objective as user scoring was based on microscopic observations and the cumulative degree of abnormality could be described, but the different phenotypes (eg, edema, small eyes) were not resolved. A different approach was developed by [@kfy250-B24] using supervised machine learning to identify developmental phenotypes. This approach is based on an initial expert classification of phenotypes and requires several rounds of classification and learning but can be used to establish concentration-response curves for cumulative phenotypic assessment. However, the same or similar instrumentation and settings would be required to apply their established models directly.

Crucial for a quantitative, unbiased approach to phenotype assessment using 2D images is a proper orientation of the fish embryos. Slight differences in the orientation and the subsequent 2D projection could lead to changes in feature detection. Therefore, in this study, an image-based detection and quantification of morphological features in zebrafish embryos was developed based on an automated system for positioning of the embryos in a capillary. Multiple morphological features were automatically extracted from zebrafish images using a custom MATLAB-based software called FishInspector. Although our workflow was developed for automated positioning in a capillary, it can also be applied to manually positioned embryos as conducted in other studies (eg, [@kfy250-B42]). However, this may be more time consuming and may introduce additional variability. In a second step, we used the analytical platform KNIME and R scripts for morphometric analysis and quantification using the coordinates of each feature detected by FishInspector.

Morphological features were complemented by video-based measurements of heart rate and behavioral effects (locomotor response at 96 h post-fertilization \[hpf\]). These two functional parameters provide further endpoints relevant for safety areas assessment and potentially linked to developmental toxicity. For instance, a comparative endpoint analysis ([@kfy250-B18]) has revealed a high correlation of behavioral endpoints with (gross) malformations of fish embryos and hence may support quantitation of overall assessment of teratogenic effects.

To demonstrate the capacity of the software for the multi-endpoint analysis, it was applied to a set of 5 model compounds representing diverse drug classes. Three compounds (methotrexate, topiramate, and dexamethasone) known to cause developmental toxicity in mammals and two compounds (glibenclamide and loratadine) as non-developmental toxicants. The performance of this method was also analyzed in the context of sensitivity differences between 3 laboratories experienced with conventional visual assessment and scoring of developmental anomalies in the zebrafish embryo. The intention was, for example, to understand whether the automatic assessment provides increased sensitivity compared with conventional assessments in other laboratories.

MATERIALS AND METHODS
=====================

### 

#### Chemicals

The following chemicals were used: loratadine (CAS-RN 79794-75-5, purity ≥ 98%, Sigma-Aldrich), metothrexate (CAS-RN 59-05-2, purity ≥ 98.5%, AppliChem), glibenclamide (CAS-RN 10238-21-8, purity ≥ 99%, Sigma-Aldrich), dexamethasone (CAS-RN 50-02-2, purity ≥ 97%, Fluka)**,** topiramate CAS-RN 97240-79-4, purity ≥ 98%, Sigma-Aldrich), all-trans retinoic acid (CAS-RN 302-79-4, purity≥ 98%, AppliChem Panreac), and N-phenylthiourea (PTU, CAS-RN 103-85-5, purity ≥ 98%, Sigma-Aldrich). Loratadine, glibenclamide, dexamethasonse, and all-trans retinoic acid were dissolved in dimethyl sulfoxide (DMSO). Test solutions were obtained by dilution of the stock solutions in embryo test medium according to the OECD testing guideline 236 ([@kfy250-B38], pH = 7.4--7.5) resulting in final DMSO concentrations of 0.01% (all-trans retinoic acid), 0.5% (loratadine and glibenclamide), and 1% (dexamethasone). The different DMSO concentrations reflect the different solubility in DMSO, that is, the concentration of DMSO was kept as low as possible to obtain full concentration-response curves for mortality and sublethal phenotypes.

#### Zebrafish Developmental Toxicity Assay Overview

Adult, healthy, and unexposed zebrafish were used for the production of fertilized eggs. We used the UFZ-OBI strain (generation F14--15), obtained originally from a local breeder and kept for several generations at the UFZ. Fish were cultured and used according to German and European animal protection standards and approved by the Government of Saxony, Landesdirektion Leipzig, Germany (Aktenzeichen 75-9185.64). Just after fertilization eggs were treated against fungal infection with a diluted Chloramine-T bleaching solution (0.5% w/v) for 60 s with gentle periodic agitation, washed twice with embryo medium and transferred into a petri dish for egg selection. Bleaching did not affect the hatching of embryos at later stages. All control embryos were hatched at 96  hpf. The bleaching was conducted to avoid carry over of fungi or microbes from the tanks. Embryos were exposed to the test compound, a solvent control and a positive control (all-trans retinoic acid at 12.5 nM) from 2 to 48 hpf and from 2 to 96 hpf, at a temperature of 28 (±1)°C (14:10 light: dark cycle). Forty eight-hour exposures were conducted in crystallization dishes covered with watchmaker glasses with a test volume of 16 ml and 16 embryos per dish. Ninety six-hour exposures were conducted in rectangular 96-well microplates (Clear Polystyrene, flat bottom, Uniplate, Whatman, GE Healthcare, Little Chalfont, UK) covered by a lid with a test volume of 400 µl (one embryo per well, 16 wells per concentration tested). No evaporation was observed during the exposure period. The different protocols were used since manual dechorionation is difficult to conduct in 96-well plates. For hydrophobic compounds (log *P* \> 4) low exposure volumes in 96-well microplates (400 µl exposure volume per embryo) may result in a (pronounced) decline in exposure concentration when compared with exposure in crystallization dishes (1000 µl volume per embryo). Therefore, for hydrophobic compounds (loratadine and glibenclamide) exposure was conducted in crystallization dishes for both the 48 and 96 h exposure in order to compensate for a potential loss of exposure concentration due to absorption in embryos and to the wells of the microplate. Tests were performed with at least 2 replicates. Renewal of the exposure solutions were performed every 24 h, except for methotrexate, for which, due to confirmation of stable exposure concentration, a 48 h renewal interval was selected (see [Supplementary Table 2](#sup1){ref-type="supplementary-material"}), and for topiramate, for which stability was assumed ([@kfy250-B35]) and no renewal was done. Phenotypic assessment by automated imaging ("Image-Based Quantification of Morphological Features" section) was conducted after assessment of lethality, behavioral effects (at 96 hpf), and visual assessment using a stereomicroscope (Olympus SZX10, Massachusetts). Visual and automatic image-based assessment of phenotypes at the UFZ was conducted for the same experiment and same fish. [Supplementary Table 1](#sup1){ref-type="supplementary-material"} shows the endpoints evaluated by visual observation. More details on the test protocol can be found in [Supplementary Table 2](#sup1){ref-type="supplementary-material"}.

### Developmental Staging Analysis

Comparison of developmental stages of zebrafish incubated at 28 (±1)°C was done using untreated embryos from 5 different stages from 32 to 96 hpf (32, 48, 72, 82, and 96 hpf). Linear regression analysis was performed to determine which of the features quantified using the FishInspector exhibit a significant correlation during normal development.

### Image-Based Quantification of Morphological Features

#### Automated imaging of zebrafish embryos

Images of zebrafish embryos were obtained using the VAST Bioimager (Union Biometrica, Gees, Belgium) ([@kfy250-B42]; [@kfy250-B43]) with the on-board camera of 10 µm resolution. Beforehand imaging embryos were dechorionated (required for 48 hpf stages only) and anesthetized with a tricaine solution (150 mg/l, TRIS 26 mM, pH 7.5). Embryos exposed in crystallization dishes were transferred to a 96-well microplate with rectangular wells. Loading of each fish from rectangular 96-well plates was done using the LP sampler (Union Biometrica, Gees, Belgium) and 4 pictures were automatically collected (two laterals, one dorsal, and one ventral image). Additionally, a video of 15 s at 30 frames per second was recorded of each embryo in lateral position for later video-based determination of the heart frequency. For the analysis, fish embryos were removed from the microtiter plates such that individuals from different concentrations were analyzed alternately. This was done to avoid time bias. The concentration of tricaine used here has been shown not to affect the heart rate frequency within the time frame (2 h) that was used for analysis ([@kfy250-B58]).

#### Feature detection using the FishInspector software

Lateral control images of embryos at 48 and 96 hpf were used initially for software development. FishInspector was developed within MATLAB environment and the source code and an executable version for windows operation system is freely available (last updated version is available via Zenodo **\[**[@kfy250-B27]\]). The detection of various features is organized hierarchically, that is, in order to locate a certain feature the locations of previously detected features are included. For example, detection of the contour of the embryo is guided by the capillary boundaries, since the embryo definitely will be located inside the capillary. Subsequently, other features are identified in a stepwise manner ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}). Hence, the detection of specific morphological features is dependent on the detection of other features and is facilitated by excluding regions that may interfere. The identification of the regions of interest was driven by visual observation and measurement of generic object properties. For example, once the contour of the fish was localized, the eye was detected by searching for a dark object either in the right or left half of the zebrafish. The detection algorithms were successively improved by using images of embryos treated with all-trans retinoic acid (used as the positive control for gross changes in body morphology). Given that establishment of a 100% correct automated feature detection would be very challenging and to allow improvement by the user, the software permits modification of the parameters used for the automated feature detection, and also manual correction if the feature is not sufficiently detected. At present, jaw morphology analysis cannot be detected automatically with the FishInspector and requires a manual annotation step, that is, label of the tip of the lower part of the mouth. The resulting output of the FishInspector is a set of *xy* coordinates of the morphological feature detected. For each image analyzed, data are exported to a single JSON file, which is a language independent open-standard file format typically used for transmitting data between applications. The boundary coordinates of multiple detected features can then be stored in a structured text file. This allows the seamless integration of the FishInspector output into custom post-processing algorithms, which can be implemented in any programming language.

#### Quantification of phenotypic features

The JSON data files were used as input in a customized KNIME workflow with R scripts ([@kfy250-B5], [@kfy250-B44]). The phenotypic features analyzed are described in [Table 1](#kfy250-T1){ref-type="table"}. Shape information (mainly length and surface area) was extracted using the "Momocs" R package ([@kfy250-B7]; [@kfy250-B13]). For extraction of the fish tail curvature, only the notochord coordinates from the tail of the fish were considered ([Supplementary Figure 2](#sup1){ref-type="supplementary-material"}). Curvatures along the tail were calculated by extracting from the smoothed notochord line the value of the second derivative when the first derivative is 0. The maximum curvature value along the tail was used for the analysis. Tail curvature was calculated using R with the package "features" ([@kfy250-B56]) using as smoother the function "smooth.spline" with a spar value of 0.9. Head size was quantified by drawing a line between the eye and otolith centroid, then an angle was taken from the otolith to the upper contour of the fish, also from the eye to the bottom contour of the fish to enclose the head region (see [Supplementary Figure 3](#sup1){ref-type="supplementary-material"}). Lower jaw position was evaluated at 96 hpf by using the manual selection on the FishInspector. To quantify the effects, the distance in the *x* coordinate between the eye centroid and the lower jaw tip was calculated (see [Supplementary Figure 4](#sup1){ref-type="supplementary-material"}). Table 1.Morphological Features Measured in the Zebrafish Using the FishInspector SoftwarePhenotypic FeatureData Exported as Json FormatParameter or MetricCorresponding Endpoint in Visual AssessmentEye sizeEye *xy* coordinatesSurface area (mm^2^)Reduced eye sizeBody lengthFish contour *xy* coordinatesLength (mm)Not assessedYolk sac sizeYolk sac contour *xy* coordinatesSurface area (mm^2^)Increased yolk sac size or abnormal morphologyOtolith-eye distanceOtolith *xy* centroid (saccule, the largest otolith)Length (mm)Not assessedPericard sizePericard contour *xy* coordinatesSurface area (mm^2^)Increased pericard sizeTail malformationsNotochord *xy* coordinatesCurvatureTail curvatureSwim bladder inflationSwim bladder contour *xy* coordinatesSurface area (mm^2^)Failure to inflate the swim bladderHead sizeFish contour *xy* coordinates, otolith, and eye centroidSurface area (mm^2^)Reduced or abnormal head sizePigmentationArea (in pixels) of pigment cells from lateral lineSum surface area (mm^2^)Not assessedLower jaw positionDistance in the *x* coordinate between eye centroid and lower jaw tipDistance (mm)Underdeveloped or abnormal jaw[^1]

Application of the workflow does not require knowledge of computer programing languages. The complete workflow only requires the use of the standard open source tools (KNIME, R, and ImageJ. The workflow is provided in Dryad, [@kfy250-B51]). Pigmentation was quantified by measuring the sum area of pigment cells along the lateral line, using the area covered by the notochord as the enclosure region. In order to validate the pigmentation analysis, embryos were exposed to increasing concentrations (0−150 µM) of N-phenylthiourea (PTU) ([Supplementary Figure 5](#sup1){ref-type="supplementary-material"}), a model compound that is known to inhibit melanization ([@kfy250-B25]).

### Heart Rate Quantification

An automated image workflow was developed using the KNIME Analytics Platform (workflow available in Dryad, [@kfy250-B51]). The zebrafish heart as the region of interest (ROI) is detected by comparing the absolute difference in pixel intensity between two consecutive frames. By using a threshold method and morphological operations, irrelevant areas were removed from the analysis. Then the pixel variance of the ROI in each frame was used to determine the heart frequency using a Fast Fourier transform with the *spectrum* function included in the base package of R.

### Locomotor Response (LMR)

The locomotor response was assessed at 96 hpf prior to the analysis with the VAST Bioimager system. Embryonic movement was tracked using the ZebraBox video tracking system (Viewpoint, Lyon, France) for 40 min in a series of light and dark periods to stimulate movement (10 min equilibration in light, followed by 20 min in dark, and a final 10 min light phase) as described in [@kfy250-B23]. The movement in the light periods was recorded using maximum intensity (1200 lux). Movement in light and dark periods was recorded using an infrared camera and the video tracking mode with a detection threshold set to 20. The temperature was continuously maintained at 28(±1) °C. Live embryos, including malformed embryos and embryos showing no inflation of the swim bladder, were considered for the analysis of the locomotor response. The percentage of effects (EC~50~) was calculated on the basis of the mean travelled distance as described in [@kfy250-B28] using the dark phase interval (10--20 min).

### Inter-Laboratory Study Design

Three laboratories participated in this study. They were: Department of Bioanalytical Ecotoxicology, Helmholtz Center for Environmental Research (UFZ), R&D Preclinical Safety, Sanofi-Aventis Deutschland GmbH, and BBD BioPhenix-Biobide. The laboratories used an agreed test protocol (described in "Zebrafish Developmental Toxicity Assay Overview" section) with minor differences between laboratories as shown in [Supplementary Table 2](#sup1){ref-type="supplementary-material"}. The UFZ was the only laboratory to include an image-based quantification of morphological features using the FishInspector (as described in "Image-Based Quantification of Morphological Features" section), heart rate quantification ("Heart rate quantification" section), and behavior analysis ("Locomotor Response (LMR)" section). Testing of the compounds was done in a blind manner at 2 of the 3 laboratories (Biobide and UFZ), that is, identity of the compounds was only released after completion of the effect assessment. The test concentrations were not harmonized between the different laboratories and were individually adjusted based on range findings or to improve the description of the concentration response curves in replicates.

### Data Evaluation

Two approaches were used for the concentration-response analysis: (a) effect quantification with continuous data normalized to the mean control value and, (b) threshold-based quantal effect data. The first approach was used for endpoints with high variability between controls of replicates, observed for heart rate, behavior, and pigmentation. For these endpoints, data were normalized to the mean control of each replicate and concentration-response curves were derived from these data. For all other endpoints (eye size, body length, yolk sac size, head size, swim bladder, jaw-eye distance, and otolith-eye distance), similar to the method proposed for obtaining benchmark responses with dichotomized continuous data ([@kfy250-B54]), a threshold value was established by analysis of the variability of about 130 control embryos of different replicates ([Supplementary Table 3](#sup1){ref-type="supplementary-material"}). Values deviating by ±2 SD were considered as indicating a deviation from the control and were used to calculate the fraction of embryos for which the appropriate endpoint was affected. For the overall cumulative effect assessment, a threshold of 2.5 SD was used given the higher likelihood that one of the features was affected randomly. Concentration-response curves were derived for all the morphological features and also for lethality and abnormalities (visual assessment) only when a clear concentration-response was observed and more than 30% of embryos were affected. To characterize responses for each chemical we derived an EC~50~ as the concentration at which 50% of the embryos were deviating from the feature as it was observed in controls. Lethal concentrations (LC~50~) and effect concentrations (EC~50~) for each endpoint were obtained with the sigmoidal dose-response (Hill-slope) equation ([equation 1](#E1){ref-type="disp-formula"}) calculated in SigmaPlot (version 13.0). $$f\left( x \right) = {\min +}\frac{\left( {\max\left. - ~min \right)} \right.}{1~ + ~\left( {}^{\frac{x}{{EC}_{50}}) - {HillSlope}} \right.}$$

Constraints for max and min were set to 100 and 0.

In order to rank the capability of an agent to produce developmental toxicity in relation to lethal effects we calculated the teratogenic index (TI), which is defined as the ratio between the LC~50~/EC~50~ and was successfully established in the Xenopus frog embryo's developmental toxicity screening assay ([@kfy250-B36]). A chemical was classified as developmentally toxic if the teratogenic index was greater than 1.2 in either developmental stage based on previous internal results obtained in the Sanofi lab (data not shown). If no mortality was observed, the chemical was considered developmentally toxic if morphological alterations were concentration-dependent reaching more than the 30% effect level. For the automatic image-based assessment, effect concentrations (EC~50~) for all endpoints were calculated based on a log-logistic model in R (LL.4 model from package drc \[[@kfy250-B45]\]). To reduce uncertainty, treatment groups with less than 4 surviving individuals were excluded from the analysis. Effect signatures of visual and image-based assessment were obtained by normalizing each effect concentration to the most sensitive feature (EC~50~ most sensitive feature/EC~50~ specific feature) for each time point (48 and 96 hpf). This allows for comparison of all features at the same scale. Hierarchical clustering was performed based on the "Manhattan" distance using the *hclust* function in R and "Ward.D2" method.

RESULTS
=======

### The FishInspector Software and Phenotype Characterization

A user-friendly platform for feature detection based on two-dimensional projection of fish embryos called FishInspector was developed. The graphical user interface of the software is illustrated in [Figure 1](#kfy250-F1){ref-type="fig"}. FishInspector is written in MATLAB and an executable version for Windows is freely available (latest software update available at Zenodo **\[**[@kfy250-B27]\]). The software has a modular structure and the MATLAB code can, in principle, be extended to include more features by programming appropriate plugins. In order to compensate for potential errors of the automated image analysis, particularly during the development of the software or in cases where it is difficult to establish error-free automated detection, the software allows user interaction and correction. Variability of image qualities depending on the source (camera and microscope settings, resolution, contrast, intensity) may impact on feature detection. Therefore, adjustable parameters were included in the software, making it possible to compensate for camera or microscope-dependent differences. In its current version the FishInspector is able to locate up to 10 different morphological features ([Table 1](#kfy250-T1){ref-type="table"}), and export their coordinates to an open format (JSON**---**JavaScript Object Notation**---**file). The average processing time was 3 h per plate (2 h unsupervised for the image acquisition and 1 h for the FishInspector analysis). It should be noted that FishInspector is not intended to detect deviations from normal phenotypes. This is done by subsequent analysis using the identified feature coordinates and existing analysis routines. The identified feature coordinates are processed subsequently in a KNIME workflow to derive their metrics ([Table 1](#kfy250-T1){ref-type="table"}, see Material and Methods, supplementary KNIME workflow in Dryad, [@kfy250-B51]). The features were chosen because of their relevance in zebrafish embryo development and the observed phenotypes of the model compound exposures.

![Screenshot of the FishInspector graphical user interface showing an image with detected regions of interest (ROIs) for each feature. The interface allows users to adjust and correct detected ROIs manually. The image shows the final corrected ROIs and the detected features are the following: a, lower jaw tip (orange); b, eye contour (green); c, fish contour (red); d, pericard (blue); e, yolk sac (green); f, swim bladder (blue); g, otolith (green); h, notochord (green); i, pigmentation (yellow). Colours refer to the online version.](kfy250f1){#kfy250-F1}

Some features can be expected to change during the course of development. So, developmental retardation would lead to changes in those parameters in particular**.** If several features that correlate during the course of normal development change in a consistent manner, this could serve as an indicator for developmental retardation. Therefore, cross-correlation of the different features was analyzed in untreated embryos from 32 to 96  hpf ([Figure 2b](#kfy250-F2){ref-type="fig"}). Body length and eye size were the most highly correlated features (*r *= 0.94 and 0.87, respectively) following by yolk sac size (*r* = **−**0.84). The eye-ear distance, a common morphological marker used to stage zebrafish embryos ([@kfy250-B4]; [@kfy250-B27]), showed a slight correlation (*r* = 0.7). However, if restricted to stages between 48 and 96 hpf, the correlation increased (*r* = 0.92, [Supplementary Figure 6](#sup1){ref-type="supplementary-material"}) and was therefore used to asses growth retardation at 96 hpf. The lower jaw position was analyzed between 72 and 96 hpf and also showed a positive correlation ([Supplementary Figure 7](#sup1){ref-type="supplementary-material"}).

![Control variability and cross-correlation of morphological features. A, Example of distribution plot for total body length obtained for control population at 96 hpf (*n* = 183). The mean and standard deviation (SD) were used to derive a threshold to detect the fraction of treated embryos that deviate from controls (see Materials and Methods). B, Cross-correlation of the morphological features over zebrafish development (from 32 to 96 hpf). The plot displays Pearson's linear correlation coefficient for every pair of variables. Correlation was based using the individual metric of each embryo (*N* = 44--79). Jaw-eye distance correlation was not included as it was only analyzed between 72 and 96 hpf (see [Supplementary Figure 7](#sup1){ref-type="supplementary-material"}).](kfy250f2){#kfy250-F2}

In fish embryo toxicity assays, DMSO is often used as carrier solvent to accelerate solubilization of hydrophobic chemicals, up to concentrations of around 1%. Therefore, effects of DMSO were also evaluated using the FishInspector software and KNIME workflows. Most of the affected endpoints exhibited EC~50~ ≥ 2% (v/v) DMSO, except for noninflation of the swim bladder and locomotor response. Both showed an EC~50~ value of around 1% DMSO ([Supplementary Table 4](#sup1){ref-type="supplementary-material"}) representing the maximum solvent concentration that was used for analyzing the effects of dexamethasone (for loratadine, glibenclamide, and all-trans retinoic maximum DMSO concentrations of 0.5%, 0.5%, and 0.01%, respectively, were used).

### Comparison of the Automated Quantitative versus Visual Analysis

To illustrate the performance of the software, we analyzed the phenotypic effects of six model compounds previously characterized in the zebrafish and mammalian models for developmental toxicity ([Supplementary Table 5](#sup1){ref-type="supplementary-material"}). First, the visual assessment and the automated quantitative assessment with the FishInspector were compared by calculating a cumulative EC~50~ representing the concentration where 50% of the embryos were affected by any of the quantified individual endpoints (swim bladder effects were excluded for this analysis). The two assessments revealed very similar effect levels ([Figure 3a](#kfy250-F3){ref-type="fig"}). However, the visual assessment did not reach an EC~50~ for dexamethasone, whereas the automated assessment**---**based mainly on morphological changes of pericard size, yolk sac size, and lower jaw position**---**was able to reveal an EC~50~ of 5 µM after 96 h of exposure.

![Comparison of quantitative versus the visual assessment of zebrafish embryo phenotypes. A, Correlation between aggregated EC~50~ values derived from the visual and the image-based quantitative automatic analysis. Dashed line indicates the line of unity. B, Concentration-response curves for decreased eye size in zebrafish embryos at 96 hpf after exposure to methotrexate obtained by visual and image-based analysis. Different symbols refer to independent replicates. C, Effect signatures obtained using visual (V) and image-based (A) assessment. The relative effects are shown by a color code from the most sensitive effect (red, 1) to no effect (yellow, 0). Areas without a value (in gray) indicate that the endpoint was not assessed. Endpoint terminology was adapted for a better comparison, as manual analysis is a subjective measure and the automatic image-based analysis gives a quantitative measure of a detailed effect (eg, eye abnormalities vs eye size, growth retardation vs otolith-eye distance). Glibenclamide at 48 hpf/96 hpf and dexamethasone at 48 hpf did not provoke any effects. *Abbreviations:* V, visual assessment; A, automatic image-based assessment using the FishInspector. ATRA, all-trans retinoic acid; LMR, locomotor response.](kfy250f3){#kfy250-F3}

EC~50~ values were also derived for each individual endpoint analyzed with the visual and automatic image-based method (see [Figure 3b](#kfy250-F3){ref-type="fig"} for an example of concentration-response curve).

[Figure 3c](#kfy250-F3){ref-type="fig"} shows the comparison between visual and image-based specific altered endpoints using a color scale that represents the EC~50~ normalized to the most sensitive endpoint for each of the time points (48 and 96 hpf).

In addition to the morphological endpoints analyzed with the FishInspector, two functional endpoints, heart rate and locomotor response for behavior analysis, were added to our analysis to increase the diagnostic power of the phenotype assessment. Loratadine showed a strong reduction in heart rate at both measurement time points. Topiramate exposure was found to alter heart rate at 96 hpf. Methotrexate and all-trans retinoic acid showed reduced locomotion in the dark phase, in contrast to topiramate and loratadine, which showed increased locomotion during light phase.

### Chemical Signatures

The measurement of each individual endpoint enabled the construction of a phenotypic signature for each compound according to the most affected endpoint. [Figure 4](#kfy250-F4){ref-type="fig"} shows these signatures with a color code scaled from no effect (yellow, 0) to specific effect (red, 1).

![Heat map of phenotypes and functional endpoints observed after chemical exposure of zebrafish embryos. The color code refers to normalized effect concentrations at the appropriate time point (48 hpf and 96 hpf). The scale ranges from no effect (0, yellow) to most sensitive endpoints (1, red). *Abbreviation:* ATRA, all-trans retinoic acid.](kfy250f4){#kfy250-F4}

### Inter-Laboratory Assessment of the Zebrafish Developmental Toxicity Assay

The five selected compounds were also evaluated in two other laboratories that are currently using visual assessment to score for developmental toxic effect in zebrafish (Sanofi and Biobide).The overall results (LC~50~, EC~50~ values) are shown in [Table 2](#kfy250-T2){ref-type="table"}. Table 2.Interlaboratory Comparison of Effect Concentrations, NOAEL, and Teratogenic Index after Embryo Exposure to the Selected Compounds at 48 and 96 hpfSubstanceType of AssessmentLaboratoryEC~50~ (µM)LC~50~ (µM)TI (LC~50~/EC~50~)Highest Tested Concentration (µM)48 hpf96 hpf48 hpf96 hpf48 hpf96 hpfLoratadineVBiobide10.781.64\>3011.51\>2.87.130VSanofi9.317.113.99.251.51.330VBIOTOX-UFZ10.340.6519.1412.821.819.726ABIOTOX-UFZ7.90.38------2.433.7MethotrexateVBiobide337.3216.1\>1000351.2\>31.61000VSanofi26075.43211011.21.3500VBIOTOX-UFZ244.48184.4357.8304.81.51.6550ABIOTOX-UFZ247.690.8------1.43.4DexamethasoneVBiobide[^a^](#tblfn3){ref-type="table-fn"}\>300\>300\>300\>300------600VSanofi\>500559[^b^](#tblfn4){ref-type="table-fn"}\>500\>500------500VBIOTOX-UFZ\>255\>255\>255\>255------255ABIOTOX-UFZ\>2555\>255\>255---\>51TopiramateVBiobide863.5198.6\>1500671.7\>1.73.41500VSanofi76732512796781.72.11000VBIOTOX-UFZ551.2284.21224.1937.92.23.21500ABIOTOX-UFZ311.758.8------3.915.9GlibenclamideVBiobide\>500\>500\>500\>500-----500VSanofi\>200\>200\>200\>200------200VBIOTOX-UFZ\>101.2\>101.2\>101.2\>101.2------101.2ABIOTOX-UFZ\>101.2\>101.2\>101.2\>101.2------[^2][^3][^4]

Only in **1** laboratory (Sanofi), dexamethasone showed a concentration-dependent increase in effects and an EC50 could be extrapolated. Based on the teratogenic index with individually set laboratory thresholds (Sanofi threshold for developmental toxicity liability of TI \> 1.2), there were 4 compounds classified as developmentally toxic compounds (loratadine, methotrexate, topiramate, and dexamethasone) and 1 (glibenclamide) classified as nondevelopmentally toxic. Glibenclamide is not reported to cause developmental toxicity in mammals.

DISCUSSION
==========

### The FishInspector as a Flexible Platform for Detecting Morphological Features

Although large-scale toxicity screens have been carried out with zebrafish ([@kfy250-B21]; [@kfy250-B40]; [@kfy250-B53]), the phenotypic assessments are typically nonquantitative or semiquantitative at best. Morphological phenotyping remains a subjective process that may vary greatly between laboratories and could be affected by the fatigue, training, and expertise of those who perform the analysis and scoring. The use of a more unbiased, quantitative phenotypic assessment using image analysis, such as the one presented in this manuscript, can mitigate the subjectivity inherent in tests that rely on phenotype observations. Aiming to reduce this potential subjective bias from zebrafish embryo morphological analysis and to potentially link phenotype patterns to mode of action in subsequent analyses, we developed the software FishInspector. It provides an integrated and user-friendly platform for feature detection based on a two-dimensional projection of fish embryos. A crucial prerequisite is that embryos are analyzed out of their chorion (requiring manual dechorionation for stages \<72 hpf) and that images are obtained after precise orientation of embryos. For instance, more than 75% eye overlap of the left and right eye in lateral two-dimensional projections was reported to be required for ear-eye distance analyses with less than 5% error ([@kfy250-B4]).

Correction of feature detection with the FishInspector is frequently required, but not for all features. For example, eye size, body length, notochord, and yolk are robust parameters that rarely need interaction or require only little correction. Other features like the jaw or pericard mostly require user correction. However, user interaction in the FishInspector is required only for the detection of the features and can also be conducted blind. Assessment of whether the chemical is provoking a certain phenotype or deviation from controls is made via concentrations-response modeling. This greatly reduces the bias if compared with visual microscopic observation and scoring. Furthermore, with the FishInspector one has an improved documentation of the analysis given that assessments can always be traced back to the original images.

Existing image analysis platforms (Molecular Devices ImageXpress, Definiens Developer software, Noldus Danioscope, Thermo Scientific Cellomics Zebrabox, or GE Healthcare Lifesciences Cell Investigator Zebrafish Analysis) do not at present allow feature annotation to the same extent or with the same flexibility or future development potential as our approach. Moreover they are not freely available as open source software, and some of them require co-purchase of certain equipment and/or have been discontinued. The FishInspector software in our study has been used in conjunction with the VAST bioimager system which automatically positions embryos in a glass capillary prior to imaging ([@kfy250-B41]). However, in principle, it is possible to use conventional pictures obtained with a bright-field microscope ([Supplementary Figure 8](#sup1){ref-type="supplementary-material"}). Therefore, we provide a simple workflow that automatically rotates the images and draws a virtual capillary. The user-friendly workflow processes multiple images simultaneously based on an imageJ macro embedded in a KNIME workflow ([@kfy250-B51]). Hence, it uses established and open source software. The workflow can easily be adapted to accommodate different image properties depending on the source of the image (eg, intensity, contrast). As for any type of image analysis, the quality of the images is critical even if manually positioned embryo images are used.

A limited number of features can be detected at present ([Table 1](#kfy250-T1){ref-type="table"}). Due to the modular architecture of the FishInspector, the plan is to increase the number of detected morphological features, including support for dorsal and ventral images. Future versions may also implement self-learning algorithms to make automatic feature detection more robust. Manually approved feature contours could be used, for example, to train Active Shape/Appearance models ([@kfy250-B14]; [@kfy250-B15]) and to minimize the need for manual correction.

Cross-correlation analysis of all the features with progressing development indicated that a subset of the morphological endpoints exhibit a high correlation and enable improved identification of growth retardation ([Figure 2b](#kfy250-F2){ref-type="fig"}), a common parameter evaluated in mammalian developmental toxicity studies. The potential confounding effects of DMSO on phenotypes and behavior was also revealed in this study. DMSO was used up to a concentration of 1%, representing the EC50 for nonswim bladder inflation and reduced locomotor activity. Effects of DMSO on locomotion have been previously reported in other studies at a concentration as low as 0.01% ([@kfy250-B12]). The effect on these parameters should be carefully interpreted (eg, reduce locomotion in dexamethasone-treated embryos in combination with 1% DMSO in our study). Hence, we suggest, in general, minimizing the amount of DMSO especially for specific examinations or considering potential interference by solvents in the interpretation of results. However, for screening purposes, maximization of the compound solubility and uptake through standardized DMSO concentrations (eg, 1%) have been used effectively with good predictivity ([@kfy250-B29]).

### Software Performance and Differences between Visual and Automated Assessment

The ability of our approach to detect developmental toxicity was demonstrated by using six compounds previously assessed by other laboratories for the optimization and performance evaluation of the zebrafish developmental toxicity assay ([@kfy250-B20]). Our image-based quantitative approach eliminates possible observation bias whereas demonstrating consistency with the overall effect assessment by visual analysis of an experienced researcher. Furthermore, automated assessment included the evaluation of two additional endpoints, body length, and pigmentation, which could not be properly evaluated by visual analysis due to its inherent subjectivity. Our approach slightly increases throughput given that the imaging is conducted unsupervised. However, the amount of data generated also increases the subsequent analysis workload. Indeed we did not primarily aim or expect to increase throughput, rather to increase content and accuracy in the morphological assessment.

Comparison between visual and automatic specific altered endpoints reveals in general good agreement, with 3 major exceptions ([Figure 3c](#kfy250-F3){ref-type="fig"}): (1) Methotrexate exposure resulted in increased incidence of embryos showing bending of the tail after 48 h of exposure. However the visual analysis was not sensitive enough to capture this effect. (2) Using visual assessment we were only able to observe a concentration-dependent effect on swim bladder inflation for dexamethasone after 96 h of exposure, but the automatic assessment revealed also a concentration-dependent increase of pericard size, reduction of yolk sac size, and reduced jaw-eye distance. (3) For loratadine exposure after 96 h, the visual assessment indicated swim bladder inflation and growth retardation as the most sensitive endpoints. However, the measurement of body length revealed that loratadine specifically affects body length of the embryo at much lower concentrations than other indicators of growth retardation. Failure to inflate the swim bladder at 96 hpf represented the most sensitive endpoint in almost all the chemical exposures and could be related to a developmental delay as untreated embryos at 96 hpf often do not have a fully inflated swim bladder ([Supplementary Figure 9](#sup1){ref-type="supplementary-material"}). The swim bladder in the developing zebrafish has been shown to be evolutionarily homologous to the mammalian lung ([@kfy250-B60]). However, it is not known whether swim bladder malformations could relate to developmental toxicity in higher vertebrates. Moreover, swim bladder development depends on blood circulation and, hence, may represent a secondary effect of disturbed vascularization ([@kfy250-B59]). Chemicals affecting heart rate (eg, β-blockers, [@kfy250-B6]) displayed a co-occurrence of missing swim bladder inflation and heart rate decrease. Therefore, as swim bladder inflation seems to be affected by many chemicals, it may have a limited diagnostic value at the 96 hpf stage. Two functional endpoints, heart rate and locomotor response, allowed us to discover potential off-target effects of drugs, like reduced heart rate after loratadine exposure. Heart and jaw abnormalities are frequently analyzed as teratogenic indicators, using transgenic or stained fish embryos. Heart morphology has not yet been included in the automatic assessment with the FishInspector, but heart rate quantification may partially capture heart malformations.

### Comparative Effect Analysis

Using the different morphological and functional endpoints quantified in our study, phenotypic signatures were derived for each chemical and scaled by normalization to the effect concentration of the most sensitive endpoint. Our data suggests that observed differences in phenotype patterns could reflect the differences in the underlying mechanism of action ([Figure 4](#kfy250-F4){ref-type="fig"}). Using the FishInspector software, a larger amount of chemicals with similar mechanisms could now be analyzed to reveal whether commonalities between compound effect patterns could be derived and linked to modes of action or common key events. In the present analysis, embryos exposed to all-trans retinoic acid and methotrexate both showed tail or body axis curvature as the most sensitive morphological feature. Both compounds are associated with neural tube defects in mammals. All-trans retinoic acid interferes with the retinoic pathway, which is especially important for anterior-posterior patterning of the spinal cord and hindbrain, neuronal differentiation, and axis elongation ([@kfy250-B52]). Methotrexate is a folate analog that acts by competitively inhibiting dihydrofolate reductase, an enzyme involved in DNA biosynthesis. This impairment in nucleotide biosynthesis can decrease mitotic rates during critical morphogenetic windows ([@kfy250-B30]). Hence, similarities in effect patterns may reflect the conversion of both pathways at neural tube organogenesis.

Our study also supports evidence for the known side effects of the antihistaminic loratadine. The most affected endpoint for loratidine exposure was reduced heart rate and body length of the embryos. Some antihistaminic compounds have been shown to reduce the heart rate by competitive inhibition of the muscarinic receptors in mammals ([@kfy250-B33]). In zebrafish, knock-down of muscarinic receptors has been demonstrated to alter cardiac β-adrenergic receptor activity ([@kfy250-B49]).

The phenotypic effect observed after exposure to the antiepileptic drug topiramate revealed growth retardation as the most affected endpoint after 48 and 96 h exposure. The use of antiepileptic drugs during pregnancy has been associated with congenital defects and developmental delay in humans ([@kfy250-B11]), however the underlying mechanism is still unknown. Our approach allowed us to identify growth retardation as the main endpoint of topiramate exposure, rather than teratogenic effects. Antiepileptic drugs are also capable of inducing neurodevelopmental effects ([@kfy250-B39]) and interfere with the GABA and AMPA/kainate glutamate receptor and block voltage-dependent sodium channels ([@kfy250-B46]). In our study we observed increased locomotion during the light phase of the locomotor response analysis, which may potentially relate to the MoA of topiramate.

Dexamethasone exposure caused reduced yolk sac size in zebrafish embryos, potentially related to the role of glucocorticoid in energy metabolism by mobilizing and relocating energy substrate stores ([@kfy250-B37]). Mammalian studies have demonstrated that glucocorticoids cause cleft palate and some studies have shown that glucocorticoids alter craniofacial development in zebrafish as well ([@kfy250-B22]). Our study also revealed an alteration in jaw development by a reduced jaw-eye distance ([Figure 3c](#kfy250-F3){ref-type="fig"}).

### Interlaboratory Assessment

The performance of our method was verified by comparing it with the visual assessments of 3 different laboratories experienced with conventional visual assessment of the zebrafish embryos. A previous interlaboratory assessment study showed that technical differences were the primary contributor to interlaboratory differences in classification of a compound as developmentally toxic using zebrafish embryos ([@kfy250-B3]). Our approach avoids score assignment based on qualitative measures of effect. The interlaboratory study showed good agreement; however dexamethasone was classified as developmentally toxic by only one laboratory (Sanofi) using the visual inspection method. The quantitative approach showed a higher sensitivity for the detection of chemical effects and the sensitivity of effect assessment for dexamethasone was increased ([Table 2](#kfy250-T2){ref-type="table"}). The overall weak effects caused by dexamethasone, however, could also be due to reduced bioavailability of the compound. It has been reported that embryonic concentrations reached only 20% of the exposure concentrations indicating a potential slow uptake and internal concentration not in equilibrium ([@kfy250-B50]). Uptake of the chemicals by zebrafish embryos was not analyzed in our study, as the focus was on feature detection and quantification of developmental toxicity. However, we consider it important that this be included in routine screens, either via appropriate TK models or by internal concentration analysis ([@kfy250-B9]) since a slow and/or limited uptake of a substance by an embryo could represent a confounding factor in the assessment of effects. Loratadine was classified as a false positive in all laboratories including the automatic image-based assessment. This compound demonstrated a high uptake in previous studies, which may have contributed to the false positive results in the assay ([@kfy250-B20]). Whether analysis with the FishInspector would lead to a higher number of false positives, however, requires a more thorough analysis of a greater number of chemicals.

CONCLUSIONS
===========

This study has demonstrated the value of the FishInspector software and quantitative analysis has been demonstrated. The FishInspector software allows an unbiased and automated quantitative assessment of morphological changes in zebrafish embryos after chemical treatment, particularly for embryos positioned to a precise orientation. Its modular architecture allows users to implement the detection of additional features. Furthermore, to facilitate automatic recognition of features and reduce user interaction, self-learning algorithms for feature detection could be considered.

SUPPLEMENTARY DATA
==================

[Supplementary data](#sup1){ref-type="supplementary-material"} are available at *Toxicological Sciences* online.
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[^1]: *Notes:* The data are exported in Json file format and used to quantify different metrics by the use of a customized KNIME workflow. The corresponding assessment using the conventional visual assessment is also shown in the table.

[^2]: Abbreviations*:* V, visual assessment; A, automatic image-based assessment using the FishInspector.

[^3]: Precipitation was observed from 350 μM.

[^4]: Effect concentration was extrapolated.
